Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases

Explore clinical trials studying Skin Diseases. Study availability and eligibility vary by location and protocol.

23,025 public trials 3,714 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases trial results

Recruiting

A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors

NCT07600476

Conditions
Basal Cell Carcinoma of Skin, Carcinoma, Carcinoma, Basal Cell, +18 more
Locations
  • Universitätsklinikum Würzburg Würzburg, Bavaria, Germany
  • Fachklinik Hornheide Münster, North Rhine-Westphalia, Germany
  • Klinikum der Ludwig-Maximilians-Universität München, Klinik und Poliklinik für Dermatologie und Allergologie Munich, Bavaria, Germany
View Trial Details
Recruiting

TT-702 in Patients With Advanced Solid Tumours.

NCT05272709

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +22 more
Locations
  • Royal Marsden Hospital NHS Foundation Trust London, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
  • University Hospital Southampton NHS Foundation Trust Southampton, United Kingdom
View Trial Details
Recruiting

A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

NCT07405801

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Avera Cancer Institute - Marshall Marshall, Minnesota, United States
  • Avera Cancer Institute - Aberdeen Aberdeen, South Dakota, United States
  • Avera Cancer Institute - Mitchell Mitchell, South Dakota, United States
  • Avera Cancer Institute - Pierre, SD Pierre, South Dakota, United States
View all 54 locations
View Trial Details
Recruiting

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

NCT05422794

Conditions
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, +9 more
Locations
  • Boston Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • NYU Langone Hospital - Long Island Mineola, New York, United States
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
View Trial Details

Related conditions